TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
ZVRA

Zevra Therapeutics Inc.

Healthcare · Biotechnology

11.10$ +3.3% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Zevra Therapeutics Inc. (ZVRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 303 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZVRA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
139 172 151 144 192 178 173 256 270 285 279 303
137 87 63 61 99 86 82 226 225 223 230 251
43 43 43 39 54 34 37 48 54 62 96 145
83 – 53 49 89 69 63 203 200 191 96 222
9.9 16 8.3 8.9 7.8 11 13 18 17 23 22 22
– 0.0 12 10 8.8 2.0 2.6 1.1 1.4 1.7 2.3 2.4
– 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7
– 69 68 66 71 69 67 7.1 6.7 6.4 6.1 5.8
72 110 102 112 122 138 132 139 137 130 73 85
22 74 30 30 34 34 27 29 26 39 47 49
0.4 – 0.6 0.6 0.5 0.4 0.6 0.5 0.4 0.4 0.4 0.6
12 14 23 20 24 13 18 16 11 2.5 12 14
44 5.1 43 58 59 60 60 61 61 62 – –
67 62 49 32 70 40 41 117 133 155 206 218
-339 -400 -416 -436 -470 -505 -508 -434 -434 -422 -384 -375
35 42 42 42 48 54 54 56 56 57 60 61

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?